Fintel reports that on October 31, 2025, HC Wainwright & Co. maintained coverage of Apellis Pharmaceuticals (NasdaqGS:APLS) with a Buy recommendation. Analyst Price Forecast Suggests 86.70% Upside As ...
Apellis Pharmaceuticals, Inc. will host a conference call and webcast on July 31, 2025, at 8:30 a.m. ET to discuss its financial results for the second quarter of 2025. Interested parties can access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results